MedTrace Logo

Program Reinforcement Impacts Self Management (PRISM)

NCT01343056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2017-06-02

Study results available
· View outcomes & findings →

Summary

Patients who receive DSME (Diabetes Self Management Education) will be enrolled in a 4 arm, randomized study with each group receiving a different method of follow up. The 4 arms will be evaluated based on clinical indicators, goal achievement and patient satisfaction.

Conditions

Interventions

BEHAVIORAL

Office Staff Support

The intervention includes the Office staff of primary care practices trained to provide diabetes support for behavioral goal setting were tasked to follow up with patients via phone following completion of diabetes self-management education.

BEHAVIORAL

Peer Support

Community peers trained to provide diabetes support for behavioral goal setting were tasked to follow up with patients via phone following completion of diabetes self-management education.

BEHAVIORAL

Usual Care Support

Diabetes educators provided patient follow up for behavioral goal setting support according to traditional clinical guidelines following completion of diabetes self-management.

BEHAVIORAL

Educator Support

Diabetes educators provided patient follow up for behavioral goal setting support that was problem-focused and patient centered.

Sponsors & Collaborators

  • Penn State University

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Linda Siminerio, RN, PhD, CDE · University of Pittsburgh

  • Robert Gabbay, MD, PhD · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-12-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01343056 on ClinicalTrials.gov